References
- Efthimiou P., Paik P. K., Bielory L. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 2006; 65: 564–72
- Fitzgerald A. A., Leclercq S. A., Yan A., Homik J. E., Dinarello C. A. Rapid responses to anakinra in patients with refractory adult‐onset Still's disease. Arthritis Rheum 2005; 52: 1794–803
- Nicklin M. J., Weith A., Duff G. W. A physical map of the region encompassing the human interleukin‐1 alpha, interleukin‐1 beta, and interleukin‐1 receptor antagonist genes. Genomics 1994; 19: 382–4
- Pyo C. W., Hur S. S., Kim Y. K., Choi H. B., Hong Y. S., Kim D. W., et al. Polymorphisms of IL‐1B, IL‐1RN, IL‐2, IL‐4, IL‐6, IL‐10, and IFN‐gamma genes in the Korean population. Hum Immunol 2003; 64: 979–89
- Arend W. P. The balance between IL‐1 and IL‐1Ra in disease. Cytokine Growth Factor Rev 2002; 13: 323–40
- Yamaguchi M., Ohta A., Tsunematsu T., Kasukawa R., Mizushima Y., Kashiwagi H., et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992; 19: 424–30
- Chen D. Y., Lan J. L., Lin F. J., Hsieh T. Y., Wen M. C. Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease. Ann Rheum Dis 2004; 63: 1300–6
- Hoshino T., Ohta A., Yang D., Kawamoto M., Kikuchi M., Inoue Y., et al. Elevated serum interleukin 6, interferon‐gamma, and tumor necrosis factor‐alpha levels in patients with adult Still's disease. J Rheumatol 1998; 25: 396–8
- Pascual V., Allantaz F., Arce E., Punaro M., Banchereau J. Role of interleukin‐1 (IL‐1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL‐1 blockade. J Exp Med 2005; 201: 1479–86
- Stojanov S., Kastner D. L. Familial autoinflammatory diseases: genetics, pathogenesis and treatment. Curr Opin Rheumatol 2005; 17: 586–99